---
title: "JD HEALTH 3Q Non-IFRS Operating Profit Up 14.3% YoY, Non-IFRS Profit Up 1.5%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/305794669.md"
description: "JD HEALTH -0.060 (-0.145%) Short selling $90.55M; Ratio 21.577% announced its results for the third quarter ended September 2026. Revenue rose 16.9% YoY to RMB20.017 billion. Non-IFRS operating profit increased 14.3% YoY to RMB1.575 billion, while non-IFRS profit added 1.5% YoY to RMB1.931 billion.(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-11-17 16:25.)"
datetime: "2026-11-17T09:19:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/305794669.md)
  - [en](https://longbridge.com/en/news/305794669.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/305794669.md)
generator: "portal-rs"
---

# JD HEALTH 3Q Non-IFRS Operating Profit Up 14.3% YoY, Non-IFRS Profit Up 1.5%

JD HEALTH (06618.HK) -0.060 (-0.145%) Short selling $90.55M; Ratio 21.577% announced its results for the third quarter ended September 2026. Revenue rose 16.9% YoY to RMB20.017 billion. Non-IFRS operating profit increased 14.3% YoY to RMB1.575 billion, while non-IFRS profit added 1.5% YoY to RMB1.931 billion.  
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-11-17 16:25.)

### Related Stocks

- [06618.HK](https://longbridge.com/en/quote/06618.HK.md)
- [86618.HK](https://longbridge.com/en/quote/86618.HK.md)

## Related News & Research

- [JD Health Trustee Purchases Shares for Post-IPO Award Scheme](https://longbridge.com/en/news/306036144.md)
- [BofAS Cuts JD HEALTH TP to HKD57; 1H Earnings Beat](https://longbridge.com/en/news/295915379.md)
- [The bank of Nvidia is getting more ‘disciplined,’ selective](https://longbridge.com/en/news/306148745.md)
- [NetEase Investigation Notice: SueWallSt Notifies Investors of Pending Investigation Into NetEase (NTES)](https://longbridge.com/en/news/306200520.md)
- [PRESS DIGEST-New York Times business news - November 20](https://longbridge.com/en/news/306242079.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**